BlackBarn Capital Partners LP
Follow13F filer, CIK 2010204, NEW YORK, NY
BlackBarn Capital Partners LP reported $1,520,651,463 across 16 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 97.22% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002010204-26-000001
- Period
- 2025-12-31
- Reported value
- $1.52B
- Holdings
- 16
- Top 10 weight
- 97.22%
- New
- 1
- Sold out
- 5
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| NIQnew | +1,800,000 | $29.7M |
| MHadded | +549,243 | $9.06M |
| CCOIadded | +275,000 | $5.93M |
| NEEadded | +65,000 | $5.22M |
| PRVAadded | +209,618 | $4.97M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ROIVreduced | -1,315,700 | -$28.6M |
| NXTexited | -350,000 | -$25.9M |
| TEVAexited | -1,000,000 | -$20.2M |
| MOHexited | -95,000 | -$18.2M |
| ACLSreduced | -103,427 | -$8.31M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0002010204-26-000001, largest first. % of portfolio is the value over $278,901,463, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ROIVROIVANT SCIENCES LTD | 3,084,300 | $66.9M | 24% | -1,315,700 | Timeline | ||
| DHCDIVERSIFIED HEALTHCARE TR | 6,530,140 | $31.7M | 11.36% | +380,140 | Timeline | ||
| PRVAPRIVIA HEALTH GROUP INC | 1,300,000 | $30.8M | 11.05% | +209,618 | Timeline | ||
| NIQNIQ GLOBAL INTELLIGENCE PLC | 1,800,000 | $29.7M | 10.64% | new | Timeline | ||
| NEENEXTERA ENERGY INC | 335,000 | $26.9M | 9.64% | +65,000 | Timeline | ||
| MHMCGRAW HILL INC | 1,400,000 | $23.1M | 8.28% | +549,243 | Timeline | ||
| AMRXAMNEAL PHARMACEUTICALS INC | 1,570,000 | $19.8M | 7.09% | -619,452 | Timeline | ||
| VKTXVIKING THERAPEUTICS INC | 550,000 | $19.3M | 6.94% | +50,000 | Timeline | ||
| CCOICOGENT COMM HOLDINGS INC | 650,000 | $14M | 5.02% | +275,000 | Timeline | ||
| ABUSARBUTUS BIOPHARMA CORP | 1,850,000 | $8.9M | 3.19% | -150,000 | Timeline | ||
| ACLSAXCELIS TECHNOLOGIES INC | 96,573 | $7.76M | 2.78% | -103,427 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| SPYSTATE STR SPDR S&P 500 ETF T SHS | put | 1,500,000 | $1.02B | +250,000 |
| RMDRESMED INC Stock | put | 400,000 | $96.3M | -300,000 |
| WRBYWARBY PARKER INC CL A COM | put | 3,000,000 | $65.4M | +2,000,000 |
| ELANELANCO ANIMAL HEALTH INC Stock | put | 1,700,000 | $38.5M | +950,000 |
| OSCROSCAR HEALTH INC CL A | put | 1,300,000 | $18.7M | +50,000 |
Sold out in Q4 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002010204-26-000001 | base | 2026-02-17 | acceptance time not in the bulk data set |